sions document the movement of stars in relation to each other, their brightness and their colour, as well as their position. Researchers can use this information to study cosmological questions -the relative motion of stars, for example, provides pointers to the age and mass of the Universe.
DIVA's main sponsor is the DLR, Germany's space agency, which had committed to paying half of the project's total cost of 57 million euros (US$51.5 million). The rest of the money was to come from five German states, one of which pulled out, leaving a Horst Kern, president of the University of Göttingen, says that the investigation into the trial has been delayed primarily by data-protection rules covering patient information. Without access to the complete files of all 18 patients involved in the trial, the external task force looking into the allegations has been unable to proceed, he says.
"We find the situation unsatisfactory," Kern says, "but we do what we can to push things along." He declines to say when the investigation will be completed.
Clinical research in Germany has come under close scrutiny since 1997, when two biomedical researchers were accused of fabricating data in scores of papers.
Eberhard Hildt, a former postdoc at the University of Ulm, who first raised the alarm over the 1997 scandal, says it is in the interests of the scientific community for the latest investigation to be completed quickly. "Data-protection problems alone are no excuse," he says. "There seem to be no similar problems with patients' data when it comes to publishing a paper." s Alleged irregularities halted a vaccine trial that had reported tumour regression.
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DIVA funding gap of 15 million euros. "We saw no way to close the gap," says Sigmar Wittig, the DLR's director. "So we had no choice but to slow down the mission's development and plan a launch for 2007 or 2008." GAIA, meanwhile, has substantially reduced its own projected costs by planning to use a Russian rather than a European launcher, which project scientists hope will help persuade ESA to fix a launch for 2010. ESA is to decide on a new scheduling programme for all its missions early this summer.
But an early launch for GAIA would render a late launch for DIVA redundant. The same redundancy might also scotch current efforts by US scientists to revive NASA's interest in FAME.
And failure to launch either of the smaller missions before the middle of this decade would damage the whole of astrometry, says Siegfried Röser of the Institute of Computational Astronomy in Heidelberg, and lead investigator for DIVA. Young scientists will steer clear of an area of research in which no new data are expected for years on end, he says.
This prospect has led some researchers to look at the possibility of combining DIVA and FAME into a single mission. "I'd look at collaboration very favourably," says Kenneth Johnston, of the US Naval Observatory in Washington DC, FAME's principal investigator. Röser says he is not averse to such a solution, but wants to see first if ESA can be persuaded to come to DIVA's aid. 
